Dr. Michael West Transitions to Non-Executive Director LOS ANGELES—(BUSINESS WIRE)—Advanced Cell Technology, Inc. (OTCBB:ACTC – News) today announced the promotion of Dr….
Webcast Scheduled for Monday, August 11, 2014 at 5:00 p.m. Eastern Time MARLBOROUGH, Mass.– Advanced Cell Technology, Inc. (“ACT”; OTCBB:ACTC), a…
Experienced Finance and Operations Executive to Join Company on June 12, 2013 MARLBOROUGH, Mass. — May 23, 2013 – Advanced…
MARLBOROUGH, Mass. – May 16, 2013 – Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of…
Patients with 20/100 Vision Will Now be Eligible for Enrollment, Expanding Patient Base and Potentially Accelerating Pace of Trials MARLBOROUGH,…
Access to Federal Funding Could Accelerate Clinical Development June 11, 2010, WORCESTER, MA – Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC) announced today…
Findings Support Use of ACT’s human embryonic stem cells WORCESTER, MA –February 11, 2010 (PR Newswire). Advanced Cell Technology, Inc….
First-Ever Designation for Treatment Using Embryonic Stem Cells WORCESTER — Advanced Cell Technology, Inc. (OTCBB: ACTC), a biotechnology company applying…
Catholic Healthcare West to become Advanced Cell Technology’s first clinical trial site for Phase II myoblast study LOS ANGELES, Calif….
Agreement Represents Progress Toward Commencing Phase II Human Clinical Trials for Myoblast Therapy Los Angeles, CA, March 5, 2008 –…